🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.

Experimental Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to contact these profiles privately for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and assertions of next-day British shipping. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Voice Concerns

However, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.

Several experts stated the demand for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the British medical regulations.

Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, marketing, and customer laws, potentially leading to fines, legal action or prison.

Platform Response and Material Removal

Based on the social media company, the platform has taken down violative material and prohibited associated hashtags and search suggestions. The organization said it was dedicated to maintaining the platform secure and investing in strengthening compliance measures.

Online Marketplace Activities

Research also found communities with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with images of weight loss, positive testimonials and detailed guides for preparing or injecting at home.

Within moments of joining one community, a vendor posted WhatsApp details, where most purchases occur. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about weight, health issues or previous experience.

Item Details and Pricing

Within these communities, messages display black plastic packages with postal service stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram stated it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they cannot confirm. Even if the science behind this drug is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has already seen individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to potentially serious health risks”.